First pre-surgery drug approved for breast cancer
from The Boston Globe
The U.S. Food and Drug Administration approved a new drug to shrink breast tumors before surgery. While oncologists sometimes use chemotherapy to treat certain breast cancers before surgery, the new drug — called Perjeta (pertuzumab) — was the first to be approved specifically for this purpose in patients with early stage breast cancers that respond to the HER2 protein.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063